SPEC Inspecs Group plc

LSE · GB · Healthcare · Medical Instruments & Supplies · inspecs.com

92.50GBP-1.07%Mkt Cap: 129.53M $P/E: —4d ago

INSPECS Group plc designs, produces, sells, markets, and distributes fashion eyewear, lenses, and OEM products in the United Kingdom, Europe, North America, South America, Asia, Africa, and Australia. It operates through…

Industry Peers

Medical Instruments & Supplies

Screen all

ISRG

Intuitive Surgical, Inc. - Common Stock

$140.43BUSDP/E 44.8

EssilorLuxottica Societe anonyme

$71.20BUSDP/E 26.7

BDX

Becton, Dickinson and Company Common Stock

$48.16BUSDP/E 30.5

MDLN

Medline Inc. - Class A common stock

$47.91BUSDP/E 44.5

RMD

ResMed Inc. Common Stock

Alcon Inc. Ordinary Shares

$30.82BUSDP/E 48.7

WST

West Pharmaceutical Services, Inc. Common Stock

$25.69BUSDP/E 46.8

DIM

Sartorius Stedim Biotech

$22.02BUSDP/E 69.2

SRT3

Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

$15.20BUSDP/E 71.6

SOLV

Solventum Corporation Common Stock

$14.95BUSDP/E 10.7

BAX

Baxter International Inc. Common Stock

$12.14BUSD

COO

The Cooper Companies, Inc. - Common Stock

$10.82BUSDP/E 19.6

AVTR

Avantor, Inc. Common Stock

$10.38BUSD

COO

The Cooper Companies, Inc.

$10.29BUSDP/E 18.6

RGEN

Repligen Corporation - Common Stock

$10.25BUSDP/E 248.9

ALGN

Align Technology, Inc. - Common Stock

$10.21BUSDP/E 25.0

ATR

AptarGroup, Inc. Common Stock

$7.62BUSDP/E 21.6

Key Statistics

Company

Market Cap129.53M USD

Enterprise Value158.35M USD

Revenue (TTM)247.83M USD

Gross Profit127.20M USD

Net Income (TTM)-12.26M USD

Revenue/Share1.90 GBP

Last Price92.50 GBP

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees1.7K

CountryGB

SectorHealthcare

IndustryMedical Instruments & Supplies

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)10.94

PEG—

EV/EBITDA8.38

EV/Revenue0.64

P/S0.52

P/B1.18

EPS (TTM)-0.04

EPS (Forward)0.08

52W Range

38.0581% of range105.00

52W High105.00 GBP

52W Low38.05 GBP

Profitability

Gross Margin51.73%

Oper. Margin5.95%

EBITDA Margin7.63%

Profit Margin-4.99%

ROE-11.99%

ROA-4.73%

Growth

Revenue Growth1.60%

Earnings Growth—

Cash Flow & Leverage

Operating CF119.28K USD

CapEx (TTM)3.02M USD

FCF Margin7.67%

FCF Yield14.68%

Net Debt37.09M USD

Net Debt/EBITDA1.96

Balance Sheet

Debt/Equity0.75

Current Ratio1.39

Quick Ratio0.75

Book Value/Sh0.78 GBP

Cash/Share0.25 GBP

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 GBP

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio0.66%

Ex-Div DateSep 1, 2022

Pay Date—

Analyst Consensus

Rating—

Target (Mean)61.81 GBP

Upside (mean)-33.2%

Target Range61.81 GBP – 61.81 GBP

# Analysts1

Ownership

Shares Out.109.17M

Float—

Insiders89.25%

Institutions8.86%

Technical

SMA 5095.76 (-3.4%)

SMA 20085.98 (+7.6%)

Beta1.60

S&P 52W Chg14.58%

Avg Vol (30d)6.39K

Avg Vol (10d)7.08K

Technical Indicators

RSI (14)9.7

MACD-0.7834

MACD Signal-0.4990

MACD Hist.-0.2844

BB Upper97.62 GBP

BB Middle94.95 GBP

BB Lower92.28 GBP

BB Width5.63%

ATR (14)3.172 GBP

Vol Ratio (20d)3.53x